Biological cytotoxicity evaluation of spiro[azetidine-2, 3'-indole]-2', 4(1'H)- dione derivatives for anti-lung and anti-breast cancer activity

Der Pharmacia Lettre

Volumn 3, Issue 5, 2011, Pages 236-243

  Sukhramani, Prakash S ^a   Sukhramani, Poonam S ^a   Tirthani, Sonal R ^b   Desai, Sarav A ^c   Suthar, Maulik P ^d  

^a Veerayatan Institute of Pharmacy   (India)

^b SIR PT Science College   (India)

^c Pioneer Pharmacy Degree College   (India)

^d GANPAT UNIVERSITY   (India)

Author keywords

4(1'H) dione derivatives; Cytotoxicity; Lung and breast cancer cell line; MTT; Spiro azetidine 2, 3' indole 2'; XTT

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTINEOPLASTIC AGENT; DOXORUBICIN; SPIRO[AZETIDINE 2,3' INDOLE] 2',4 (1'H)DIONE DERIVATIVE; TETRAZOLIUM; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DETERMINATION; DRUG MECHANISM; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IC 50; LUNG CANCER; NONHUMAN;

EID: 80955139283     PISSN: None     EISSN: 09755071     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. P. S. Sukhramani; S. A. Desai; M. P. Suthar. Journal of Pharmacy Research 2011, 4, 1, 124-127.
2. G. S. Singh; E. Mbukwa, T Pheko. ARKIVOC 2007, (ix), 80-90.
3. D. P. Maia; D. V. Wilke; J. Mafezoli; J. N. da Silva; M. O. de Moraes; C. Pessoa; L. V. Costa-Lotufo. Chemico-Biological Interactions 2009, 180, 2, 220-225.
4. M. J. Meega; M. Carr; A. J. S. Knox; D. M. Zisterer; D. G. Lloyd. Journal of Enzyme Inhibition and Medicinal Chemistry 2008, 23, 5, 668-685.
5. I. R. Freshney. 5th ed., Wiley-Liss, New York. USA: 2005, pp. 200-1, 209-11, 213-4, 251, 328-32, 335-8, 359-70, 508.
6. R. M. Patel; N. J. Patel. International Journal of Pharmaceutical Research, 2010, 2, 1, 88-99.